Introduction
Normal fetal growth results from the normal progression of discrete developmental events that occur throughout gestation. The degree to which fetal growth results from a developmental "program" intrinsic to the fetus or is regulated by maternal or other external factors is not known. This is understandable since the cellular mechanisms comprising normal embryonic and fetal development are not fully understood. A major developmental event occurs at -10 wk gestation when an acceleration in fetal growth velocity takes place (1) . This acceleration represents not only total fetal weight but is due primarily to cellular hyperplasia in fetal organs (2) . While the molecular basis for this accelerated growth is unknown, possible regulatory roles for tissue growth factors and cellular oncogenes during fetal development have been postulated (3) (4) (5) .
The placenta is a logical source of fetal cells to study the cellular mechanisms regulating fetal growth. It is the only fetal organ whose sole function is to maintain an optimal milieu for fetal development. Consequently, fetal growth is dependent upon placental well-being. Like other fetal tissues the placenta undergoes a specific sequence of growth and differentiation over a short time period (6) . Specifically, the placenta undergoes a similar acceleration in growth rate at the end of the first trimester (7) . Since tissue-specific mesenchymal cells are essential for normal organ development (8) placental fibroblasts were used as a model system to begin studying the cellular mechanisms regulating human placental growth.
Materials
Sources ofmaterial. Term placental tissue was obtained from normal, nonlabored pregnant women undergoing repeat caesarean section at 38-41 wk gestation. Preterm placental tissue was obtained from elective therapeutic abortions between 7 and 19 wk gestation. Placentae were obtained in accordance with a protocol and consent form approved by the Institutional Review Board of the University of Texas, Southwestern Medical Center, Dallas, Texas. Dulbecco's modified Eagle's medium, penicillin, streptomycin, fetal calf serum, nystatin, and all plastic culture dishes were purchased from Gibco Laboratories, Placental fibroblast culture. Placental tissue, dissected free of decidua and membranes, was subjected to enzymatic digestion for 30 min at 370C by 0.1% collagenase, 0.1% hyaluronidase, and 0.01% DNase in DMEM (5 ml/gm). The dispersed cells were filtered through a 15-ym nylon mesh. The cells were centrifuged (100 g), resuspended in 10 ml DMEM containing 10% FCS, penicillin (100 U/ml), streptomycin (100 ,og/ml), and seeded into T-25 culture flasks. The cells were allowed to attach overnight. The media were changed the next day and every 3-4 d thereafter. The fibroblastoid cells proliferated while the trophoblasts tended to degenerate during the second week of culture. When confluent the cells were passaged in a 1:4 split ratio. By the second passage an apparently homogeneous population of fibroblastoid cells remained. The fibroblasts were grown in T-75 flasks in DMEM, 10% FCS, in a humidified incubator containing 5% CO2. The medium was harvested every 3-4 d. The cells were removed by trypsinization and replated every week (1:4 passage dilution).
Characterization of cell strains. Mesenchymal cells were isolated from the chorionic villi ofhuman placentae at 7-19 wk gestation. Ges-tational age was determined by maternal dates and confirmed by foot length measurements (9) when possible. The cells were grown in DMEM supplemented with 10% FCS from identical lots in most cases. Otherwise, only lots that performed similarly in growth-promoting assays were used. Cells were used for growth studies between the third and seventh passages. The cells were characterized by immunohistochemical techniques as described later. The fibroblastoid character of cells derived from 9-and 19-wk placentae was confirmed by the positive staining ofvimentin along with negative staining for desmin, factor VIII antigen, keratin, and a-HCG. This screen effectively ruled out the presence of differentiated vascular smooth muscle cells, endothelial cells, and trophoblasts (10) (11) (12) . Additionally, each cell strain was karyotyped. Only cell strains with normal chromosomes by karyotype analysis were included in these studies.
Cellular binding of ['25I]-IGF-I and ['25I]-EGF. IGF-I was iodinated to a sp act of200-300 uCi/zg by a modification ofthe chloramine-T procedure ofHunter and Greenwood (13), as described by Rechler et al. (14) . Fibroblasts of 15 wk gestation were grown to confluence in 1.6-cm wells as described. The medium was changed to serum-free medium and incubated further for 48 h. After 48 h the cells were washed with serum-free medium and incubated with IGF-I (100 ng/ ml), EGF (10 ng/ml), or control medium for 4 h. The cells were then washed three times with Earle's balanced salt solution, pH 7.4. Radiolabelled IGF-I or EGF (20, At that time 0.4 ml disuccinimidyl suberate was added at a concentration of0.200 mM and incubated for 15 min at room temperature. The reaction was quenched with 1.2 ml ice cold 10 mM Tris/l mM EDTA.
The cells were solubilized in 75 gl 2% SDS, 100 mM dithiothreitol.
Lysates from three wells were pooled, transferred to 1.5-ml microfuge tubes, and boiled for 3 min. The lysates were subjected to 10% SDS-PAGE. The gels were dried and subjected to autoradiography in the presence of Dupont intensifying screens at -80°C.
Thymidine incorporation. Confluent monolayers of placental cells (passage [4] [5] [6] 5 , and G2/M were estimated by assuming normal distributions for the GI and G2/M peaks as described (16) . At least 1,000 cells were counted per cell strain for analysis. Absolute phase times were calculated from the phase distribution based upon the following relationships: Gestao cna! Ace -weeks- Figure 1 . (A) Doubling times of placental fibroblasts at various gestational ages. Doubling times from at least three passages between the third and seventh passage were determined and averaged for one cell strain at each gestational age. The data are expressed as the mean±SEM (n = 3-4). (B) Average doubling times of placental fibroblasts shown in A were grouped according to gestational age range (7-9 wk and 10-19 wk) and averaged. The difference between the means of the two groups is statistically significant (P < 0.001).
Cell cycle analysis performed on mithramycin-stained cells revealed that rapidly growing cells (15 and 19 wk) exhibited much shorter G1 phases than the more slowly growing cells at 7 and 8 wk gestation (10-13 h vs. 40-47 h, Table I ). The G2/M phase was also somewhat shorter suggesting the presence of a G2 restriction point in these cells. It appears, however, that the major difference in cycling time for these two groups of cells resides in the length of GI.
Cellular responsiveness to growth factors. To determine if the enhanced proliferative rates of the cell strains could be explained, in part, by altered responsiveness to specific peptide growth factors (GF), the abilities of IGF-I, EGF, and FGF to stimulate DNA synthesis in these cells were tested. Each GF alone was capable of stimulating DNA synthesis in a dose-dependent manner. While the dose response curve for each GF was the same in both groups of cells, the cells derived from 10-19-wk placentae tended to have a greater maximum response than the cells studied at earlier gestations. It was difficult to quantify this difference, however, because ofthe significant variation exhibited by individual cell strains between experiments. The basal activity was similar in both groups of cells. When various combinations of GFs were tested at maximal stimulating doses, however, a major difference was noted between the two groups of cells. The combinations of IGF-I + EGF and IGF-I + FGF resulted in apparent additive stimulation of DNA synthesis in cells derived from an 8-wk placenta (Fig. 3 A) . The same combinations of GFs, by contrast, inter- acted synergistically in cells derived from a 19-wk placenta (Fig. 3 B) . When the combination ofIGF-I and EGF was tested in the other cell strains, a much stronger interaction was consistently observed in cells derived from 10-19-wk placentae compared to the responses observed in cells derived from 7-9-wk placentae (Fig. 4 A) . When the 7-9-wk cells were compared to the 10-19-wk cells the difference in their responsiveness was statistically significant (Fig. 4 B) . Similar gestational age-dependent differences in the cellular responsiveness were seen with the combination of IGF-I and FGF as well (Fig. 5, A and B). By contrast, the combination of EGF and FGF resulted in additive stimulation of DNA synthesis suggesting that their mitogenic signals proceed along distinct, noninteracting pathways (data not shown). While the doubling times exhibited by the cells were significantly different, -the time course for thymidine incorporation was similar for both groups (22-32 h ). This time course is intermediate to the lengths of Gl exhibited by the two groups of cells (10-13 h and 40-47 h). It has been previously shown that the ability of cells to be "rescued" from GO, reenter G1, and progress to S phase frequently requires a longer period of time than it takes to traverse GI in sparse, exponentially growing cells (17). Moreover, the amount oftime necessary to leave GO and reenter Gl varies with the length oftime the cells are quiescent. This suggests that cellular quiescence resulting from density inhibition and serum starvation occurs at similar points in GI before S phase in both groups of placental fibroblasts. The population of cells responsive to GF stimulation would there- Fibroblasts from different gestational ages were maintained in culture as previously described. Three wells were incubated with IGF-I (100 ng/ml) and EGF (10 ng/ml) alone. Three tandem wells were treated with IGF-I and EGF simultaneously. DNA systhesis resulting from the simultaneous addition of IGF-I and EGF was divided by the sum of the individual effects of IGF-I and EGF. This value is expressed as a single ratio. Purely additive effects would result in a ratio of 1 whereas synergistic effects would result in ratios > 1. (A) Representative ratios from fibroblasts of different gestational ages. (B) Ratios shown in A were placed into two groups (7-9 wk, 10-19 wk) and averaged. The data represent the mean±SEM. The difference between the means of the two groups is statistically significant (P < 0.05).
fore reenter G1 at similar times relative to S phase and result in similar time courses of thymidine incorporation.
To determine the time during the cell cycle that the mitogenic pathways for IGF-I, FGF, and EGF interact, sequential addition experiments were performed on cells of 19 wk gestation. When IGF-I was added to the cells up to 8 h after FGF or EGF, maximal stimulation of DNA synthesis is observed. By contrast, if FGF or EGF is added after IGF-I, much less potentiation is observed (Fig. 6, A and B) . These data suggested that FGF and EGF act at a time early in the cell cycle to enhance the cellular responsiveness to IGF-I. This is consistent with the competence/progression model of cell cycle regulation previously put forth (18). teractions. Placental fibroblasts were exposed to conditions identical to those described above, except FGF (100 ng/ml) was used instead of EGF. The difference between the means of the two groups is statistically significant (P < 0.05). (Table II) [1251]-IGF-I was covalently crosslinked to 10-and 15-wk placental fibroblasts and subjected to SDS-PAGE (Fig. 7) . Autoradiography revealed no increase in labelling ofthe a-subunit ofthe IGF-I receptor in the presence ofEGF (10 ng/ml) or EGF (100 ng/ml). These data argue that the potentiation of GF interactions observed in these cells cannot be explained by the simple heterologous regulation of cellular binding capacity or affinity.
Discussion
The data presented in this report suggest that mesenchymal cells derived from human placental tissue undergo a developmental change resulting in an increased rate of proliferation, (21) . IGF binding proteins may act to modulate IGF bioactivity at the cellular level (22) (23) . It is likely, therefore, that altered expression ofIGFs, IGF binding proteins, or IGF receptors can influence the mitotic activity of placental cells during gestation. The placenta also produces other peptide GFs, i.e., transforming growth factor-# and platelet-derived growth factor-like peptides (24) (25) , that may likewise influence mitotic activity.
The data reported here support the concept that the ability of peptide GFs to elicit the mitogenic response is a function not only of the concentration of GF but also a function of the intrinsic cellular responsiveness to that specific GF or combination of GFs. The expression of factors that attenuate or augment GF signals are, therefore, likely candidates to regulate mitotic activity. Their altered expression throughout gestation may significantly alter the cellular response to mitogenic signals, in vivo. The inability of IGF-I or EGF to influence the cellular binding of the heterologous peptide suggests that the mitogenic pathways for each peptide interact at point(s) early in the cell cycle distal to the receptor binding site. The second messenger systems involved in mediating the mitogenic signal ofeach GF, therefore, are likely points ofinteraction and signal amplification. Interactions or "crosstalk" between signalling pathways have been well described in several cell culture systems (26) (27) (28) (29) . Additionally, protooncogenes have been closely linked to the proliferative response ofcells and may function as important components of signalling pathways used by peptide GFs. Moreover, protooncogene expression occurs throughout embryonic and fetal development and does so in a tissue-specific and developmentally regulated manner (3, 4, 25, (30) (31) (32) (33) . The second messenger systems used by IGF-I, FGF, and EGF to elicit the mitogenic response in placental fibroblasts have not been defined. Characterization of these pathways should help delineate the molecular basis for the enhanced cellular response to their combined stimulation.
In summary, the proliferation rates ofplacental fibroblasts, in cell culture, bear a striking relationship to developmental age. Moreover, the appearance of rapidly dividing cells in culture coincides with the acceleration of fetal growth that begins at the end ofthe first trimester. This would suggest that accelerated fetal growth represents, in part, a developmental change intrinsic to some fetal cells. The cellular responsiveness to mitogenic growth factors also appears to be related to developmental age. While this increased responsiveness may account for part of the enhanced proliferative rate observed for these cells, the full complement of cellular mechanisms that determine this phenotype remain to be defined. The fact that the enhancement in proliferative rate and GF responsiveness are stable in cell culture provides an opportunity to define the cellular basis of this phenotype and, hopefully, delineate important mechanism(s) regulating normal fetal growth.
